{"id":2214,"date":"2022-10-24T09:54:33","date_gmt":"2022-10-24T09:54:33","guid":{"rendered":"https:\/\/eavpt23.org\/?page_id=2214"},"modified":"2023-06-06T07:48:44","modified_gmt":"2023-06-06T07:48:44","slug":"ecvpt-cardiorenal-therapeutics-symposium","status":"publish","type":"page","link":"https:\/\/eavpt23.org\/index.php\/eavpt-home\/ecvpt-cardiorenal-therapeutics-symposium\/","title":{"rendered":"CARDIORENAL SYMPOSIUM"},"content":{"rendered":"

\"\"<\/p>\n

Save the date:<\/strong>
\nECVPT Cardiorenal Therapeutics Symposium for practitioners
\n2nd July 2023, Bruges Meeting and Convention
\nCentre (BMCC), Bruges, Belgium<\/p>\n

Decision making in the pharmacological management of cardiac and renal diseases in dogs and cats requires multiple factors to be taken into account to achieve the desired therapeutic outcome. Eight international experts will present the most recent evidence on which these decisions can be made and is tailored to general practitioners with a keen interest in cardiovascular and renal therapeutics.<\/p>\n

Evidence-based and practically orientated reviews will provide practitioners with the most up-to-date evidence on which therapeutic decision making can be based, and will be supported by a series of interactive case presentations to illustrate the decision-making process that can directly be implemented in clinical practice.<\/p>\n

In addition, the symposium is forward-looking predicting the use of two new groups of therapeutic agents (SGLT2-inhibitors and HIF prolyl hydroxylase inhibitors) in veterinary medicine. The SGLT2 inhibitors appear to have beneficial effects in both cardiac and renal patients and the HIF prolyl hydroxylase inhibitors are a novel approach to the management of anaemia associated with chronic kidney disease.<\/p>\n

This symposium is a must for general and specialist practitioners wanting to keep up-to-date with cardiovascular and renal therapeutics enabling them to make evidence-based therapeutic decisions to enhance the management of their cardiac and renal patients. It will also be of interest to those in academia teaching students cardiorenal therapeutics.<\/strong><\/em><\/p>\n

Pre-congress practitioners\u2019 day organised in collaboration with EAVPT2023<\/p>\n

The symposium is accredited as approved continuing education for veterinarians in Belgium and Germany<\/strong>. It has been approved in Belgium by the \u201cNederlandstalige Gewestelijke raad der Orde der Dierenartsen\u201d (NGROD) and in Germany by the \u201cAkademie f\u00fcr tier\u00e4rztliche Fortbildung\u201d (Academy for Veterinary Continuing Education) (ATF) of the \u201cBundestier\u00e4rztekammer\u201d (Federal Chamber of Veterinary Surgeons).<\/em><\/p>\n

The symposium is accredited for veterinarians in the Netherlands<\/strong>. It has been approved by PE-veterinair (5 CE credits).<\/em><\/p>\n<\/div>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/th>\nMeet the speakers:<\/th>\n<\/tr>\n<\/thead>\n
\"\"<\/td>\nDr. Jenny Wilshaw<\/strong>
\nDr Jenny Wilshaw is a data scientist at the Royal Veterinary
\nCollege (RVC). For her PhD she developed a clinical predictive
\nmodel to help primary care vets identify which dogs with
\npreclinical myxomatous mitral valve disease (MMVD) would
\nbenefit from treatment (The HAMLET Study). She now mainly
\nworks with data from the RVC\u2019s hospitals and the large
\nVetCompass resource of electronic healthcare records with a
\nfocus on applied solutions. Jenny will discuss the results of her
\nstudies which have been published recently in the Journal of Veterinary Internal
\nMedicine and determine how to identify dogs in stage B2 MMVD that will benefit
\nfrom treatment.<\/td>\n<\/tr>\n
\"\"<\/td>\nProfessor Adrian Boswood<\/strong>
\nProfessor Adrian Boswood graduated from Cambridge
\nUniversity Veterinary School in 1989. After graduation he spent
\na year in mixed practice. In 1990 he joined the Royal Veterinary
\nCollege, University of London as an intern and he has worked
\nthere ever since. He is currently Professor of Veterinary
\nCardiology and holds the position of Vice Principal for Learning,
\nTeaching and Assessment. He obtained the RCVS Diploma in
\nVeterinary Cardiology in 1996 and the ECVIM Cardiology Diploma in 2001. He is
\npast President of the European College of Veterinary Internal Medicine. His main
\nresearch interests lie in the diagnosis, progression and treatment of acquired
\ncanine cardiovascular diseases. He has a particular interest in myxomatous mitral
\nvalve disease and has been involved in a number of influential clinical trials.
\nAdrian was the lead author of the EPIC study which demonstrated the
\nremarkable beneficial effects of pimobendan in stage B2 MMVD. In his talk he will
\ndiscuss the possible ways in which pimodendan benefits canine patients in this
\nstage of this common cardiac disease.<\/td>\n<\/tr>\n
\"\"<\/td>\nProfessor Pascale Smets<\/strong>
\nProfessor Pascale Smets received her master\u2019s degree in
\nVeterinary Medicine in 2006 at the University of Ghent. After
\nsuccessfully obtaining her PhD degree in internal medicine in
\n2011, she started an alternative residency program at the
\nEuropean College of Veterinary Internal Medicine (ECVIM-ca),
\nsubspecialty cardiology. In 2015 she became an ECVIM-ca
\ndiplomate in cardiology and returned to Ghent University. In
\n2017 she was appointed a tenure track professorship with main
\nfocus on research, teaching and clinical work in the Small Animal Department.
\nPascale will discuss the knotty problem of how to treat congestive heart failure in
\nthe patient with concomitant kidney disease, an issue that is frequently faced by
\ngeneral practitioners.<\/td>\n<\/tr>\n
\"\"<\/td>\nProfessor Harriet Syme<\/strong>
\nProfessor Harriet Syme graduated from and now works at
\nthe Royal Veterinary College, London having done an
\ninternship and residency in small animal internal medicine
\nat Purdue University in the USA. Her clinical and research
\ninterests are in nephrology\/urology, hypertension and
\nendocrinology. She is also involved in providing pastoral
\nsupport for students and in training residents. She is a
\ncurrent member of the International Renal Interest Society
\nchairing their awards committee. Hattie will discuss the new class of drugs, SGLT2
\ninhibitors which have shown great promise in human medicine in both diabetic
\nand heart failure patients. Hattie will discuss their potential applications to
\nveterinary patients.<\/td>\n<\/tr>\n
\"\"<\/td>\nDr. Astrid van Dongen<\/strong>
\nDr Astrid von Dongen graduated as a veterinarian from Utrecht
\nUniversity, worked in several first opinion clinics for a number
\nyears and then returned to university to complete an internship
\nand residency internal medicine of companion animals. She has
\nsince focused most of her working life on renal disease in dogs
\nand cats by way of patient care, international collaboration and
\neducation. Until last year she was an active member of the
\nInternational Renal Interest and is a previous President of IRIS. Astrid will discuss
\nthe way in which the most appropriate treatments should be selected for dogs
\nwith different type of glomerular disease.<\/td>\n<\/tr>\n
\"\"<\/td>\nProfessor Dominique Paep<\/strong>e
\nProfessor Dominique Paepe graduated as veterinarian at Ghent
\nUniversity in 2003, became Diplomate ECVIM-CA internal
\nmedicine in 2009 and obtained a PhD degree in Veterinary
\nSciences in 2014. She is full-time appointed as Professor in internal
\nmedicine at Ghent University, combining teaching activities,
\nresearch and clinical work. Her main research focus can be found
\nwithin the field of small animal nephrology for which was rewarded
\nwith the \u201cIRIS Award\u201d in 2016. Dominique will discuss the
\nmanagement of hypertension in cats where both the renal and cardiovascular
\nconsequences of this condition need to be considered.<\/td>\n<\/tr>\n
\"\"<\/td>\nDr. Sarah Spencer<\/strong>
\nDr Sarah Spencer graduated from the University of Bristol in
\n2012. She returned there to complete an internal medicine
\nresidency and became a Diplomate of the European College of
\nVeterinary Internal Medicine in 2018. Sarah is currently studying
\nfor a PhD at the Royal Veterinary College, investigating the role
\nof the mineralocorticoid receptor in feline chronic kidney
\ndisease and hypertension. Sarah will discuss the case for using
\nmineralocorticoid receptor antagonists in the management of feline hypertension.<\/td>\n<\/tr>\n
\"\"<\/td>\nProfessor Jonathan Elliott<\/strong>
\nProfessor Jonathan Elliott is currently Professor in Veterinary
\nClinical Pharmacology at the Royal Veterinary College. A
\nCambridge Veterinary Graduate, his PhD was in vascular
\nbiology at the Department of Pharmacology in Cambridge
\nand post-graduate clinical training was undertaken at the
\nUniversity of Pennsylvania. He joined the RVC in 1990 as a
\nlecturer in Veterinary Pharmacology and developed research interests in feline
\nkidney disease and hypertension and equine laminitis. He is currently an IRIS
\nBoard member having served as President of IRIS. Jonathan will discuss a new
\ngroup of drugs, the HIF prolyl hydroxylase inhibitors and their use to manage
\nanaemia associated with chronic kidney disease in veterinary species.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
DOWNLOAD PROGRAMME<\/span><\/a><\/div>
<\/div><\/div>
<\/div><\/div><\/span>

Registration details<\/h1><\/span>
<\/div><\/div><\/div>

Because of the generous sponsorship of Ceva, IDEXX Laboratories and Elanco Animal Health, the registration fee is \u20ac 120,00 for practitioners and \u20ac 60,00 for
\nthose currently undertaking post-graduate training (internship, residency or PhD training).<\/p>\n<\/div>

The symposium is accredited as approved continuing education for veterinarians in Belgium and Germany<\/strong>. It has been approved in Belgium by the \u201cNederlandstalige Gewestelijke raad der Orde der Dierenartsen\u201d (NGROD) and in Germany by the \u201cAkademie f\u00fcr tier\u00e4rztliche Fortbildung\u201d (Academy for Veterinary Continuing Education) (ATF) of the \u201cBundestier\u00e4rztekammer\u201d (Federal Chamber of Veterinary Surgeons).<\/p>\n

The symposium is accredited for veterinarians in the Netherlands<\/strong>. It has been approved by PE-veterinair (5 CE credits).<\/p>\n<\/div>

<\/span><\/div>
<\/div><\/div>
REGISTER NOW<\/span><\/a><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":2076,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-2214","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/pages\/2214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/comments?post=2214"}],"version-history":[{"count":32,"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/pages\/2214\/revisions"}],"predecessor-version":[{"id":2975,"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/pages\/2214\/revisions\/2975"}],"up":[{"embeddable":true,"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/pages\/2076"}],"wp:attachment":[{"href":"https:\/\/eavpt23.org\/index.php\/wp-json\/wp\/v2\/media?parent=2214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}